Sotatercept in patients with osteolytic lesions of multiple myeloma. [electronic resource]
Producer: 20140731Description: 814-23 p. digitalISSN:- 1365-2141
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers
- Bone Density
- Female
- Humans
- Immunologic Factors -- administration & dosage
- Male
- Middle Aged
- Multiple Myeloma -- complications
- Neoplasm Staging
- Osteogenesis
- Osteolysis -- etiology
- Recombinant Fusion Proteins -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.